More than 150 years of back-tested data paints a clear picture of what may come next for Wall Street's major stock indexes.

The S&P 500 Index ($SPX) (SPY) today is down -1.94%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.75%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -3. ...

While the Dow added 159 points, the Nasdaq logged its fourth straight loss -- and its third consecutive triple-digit drop -- dragged lower ahead of Nvidia's (NVDA) earnings report. The S&P 500 ...

In this video, I will go over the recent updates regarding CrowdStrike (NASDAQ:CRWD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the special offer link below. *Stock prices ...

That said, at $262, TSLA is still sitting on gains of over +40% in the last two years which has roughly matched the S&P 500 but has trailed the Nasdaq ... time to buy the drop in Tesla’s ...

Vertiv Holdings (NYSE: VRT), a critical infrastructure provider, recently saw its stock price drop following its latest earnings release, causing investors to reevaluate the company's position.

In today's video, I discuss Nvidia (NASDAQ: NVDA) and recent updates affecting the semiconductor giant. To learn more, check out the short video, consider subscribing, and click the special offer ...

Zillow's (NASDAQ: Z) stock didn't do well after earnings, but the company continues to perform well where it matters. Rentals and mortgages are up, and the company is becoming more profitable each ...

On the other hand, the Dow registered a loss of 1.55%, and the technology-centric Nasdaq decreased by 0.35%. Coming into today, shares of the jewelry company had lost 15.9% in the past month.

Full-year revenues declined 27.5% year over year to $268 million from $370 million. The drop was primarily led by weaker coal and soda ash pricing, offset by one-time carbon-neutral revenues and ...

Amphastar Pharmaceuticals (NASDAQ:AMPH), a company involved in the development and commercialization of generic and proprietary pharmaceutical products, announced its financial results for the ...